Prevalence of Radiologically Isolated Syndrome and White Matter Signal Abnormalities in Healthy Relatives of Patients with Multiple Sclerosis

REFERENCES

1. 1.↵
   1. Compston A,
   2. Coles A

   . Multiple sclerosis. Lancet 2002;359:1221–31

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Weinshenker BG,
   2. Bulman D,
   3. Carriere W,
   4. et al

   . A comparison of sporadic and familial multiple sclerosis. Neurology 1990;40:1354–58

   CrossRef
3. 3.↵
   1. Siger-Zajdel M,
   2. Filippi M,
   3. Selmaj K

   . MTR discloses subtle changes in the normal-appearing tissue from relatives of patients with MS. Neurology 2002;58:317–20

   CrossRef
4. 4.↵
   1. O'Gorman C,
   2. Lin R,
   3. Stankovich J,
   4. et al

   . Modelling genetic susceptibility to multiple sclerosis with family data. Neuroepidemiology 2013;40:1–12

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Sadovnick AD,
   2. Yee IM,
   3. Ebers GC,
   4. et al

   . Effect of age at onset and parental disease status on sibling risks for MS. Neurology 1998;50:719–23

   CrossRef
6. 6.↵
   1. Prokopenko I,
   2. Montomoli C,
   3. Ferrai R,
   4. et al

   . Risk for relatives of patients with multiple sclerosis in central Sardinia, Italy. Neuroepidemiology 2003;22:290–96

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Ramagopalan SV,
   2. Dobson R,
   3. Meier UC,
   4. et al

   . Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 2010;9:727–39

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Hensiek AE,
   2. Seaman SR,
   3. Barcellos LF,
   4. et al

   . Familial effects on the clinical course of multiple sclerosis. Neurology 2007;68:376–83

   CrossRef
9. 9.↵
   1. Ebers GC,
   2. Koopman WJ,
   3. Hader W,
   4. et al

   . The natural history of multiple sclerosis: a geographically based study: 8: familial multiple sclerosis. Brain 2000;123(Part 3):641–49

   Abstract/FREE Full Text
10. 10.↵
    1. Tipirneni A,
    2. Weinstock-Guttman B,
    3. Ramanathan M,
    4. et al

    . MRI characteristics of familial and sporadic multiple sclerosis patients. Mult Scler Dec 11, 2012 [Epub ahead of print]
11. 11.↵
    1. Siger-Zajdel M,
    2. Selmaj K

    . Magnetisation transfer ratio analysis of normal appearing white matter in patients with familial and sporadic multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;71:752–56

    Abstract/FREE Full Text
12. 12.↵
    1. Siger-Zajdel M,
    2. Selmaj KW

    . Proton magnetic resonance spectroscopy of normal appearing white matter in familial and sporadic multiple sclerosis. J Neurol 2005;252:830–32

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Okuda DT,
    2. Mowry EM,
    3. Beheshtian A,
    4. et al

    . Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 2009;72:800–05

    CrossRef
14. 14.↵
    1. Barkhof F,
    2. Filippi M,
    3. Miller DH,
    4. et al

    . Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120(Part 11):2059–69

    Abstract/FREE Full Text
15. 15.↵
    1. Granberg T,
    2. Martola J,
    3. Kristoffersen-Wiberg M,
    4. et al

    . Radiologically isolated syndrome: incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review. Mult Scler 2013;19:271–80

    Abstract/FREE Full Text
16. 16.↵
    1. Polman CH,
    2. Reingold SC,
    3. Banwell B,
    4. et al

    . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Swanton JK,
    2. Fernando K,
    3. Dalton CM,
    4. et al

    . Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2006;77:830–33

    Abstract/FREE Full Text
18. 18.↵
    1. De Stefano N,
    2. Stromillo ML,
    3. Rossi F,
    4. et al

    . Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. PLoS One 2011;6:e19452

    CrossRefPubMed
19. 19.↵
    1. Filippi M,
    2. Campi A,
    3. Martino G,
    4. et al

    . A magnetization transfer study of white matter in siblings of multiple sclerosis patients. J Neurol Sci 1997;147:151–53

    CrossRefPubMedWeb of Science
20. 20.↵
    1. De Stefano N,
    2. Cocco E,
    3. Lai M,
    4. et al

    . Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis. Ann Neurol 2006;59:634–39

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Tienari PJ,
    2. Salonen O,
    3. Wikstrom J,
    4. et al

    . Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings. J Neurol Neurosurg Psychiatry 1992;55:883–86

    Abstract/FREE Full Text
22. 22.↵
    1. Lynch SG,
    2. Rose JW,
    3. Smoker W,
    4. et al

    . MRI in familial multiple sclerosis. Neurology 1990;40:900–03

    CrossRef
23. 23.↵
    1. Dolic K,
    2. Weinstock-Guttman B,
    3. Marr K,
    4. et al

    . Risk factors for chronic cerebrospinal venous insufficiency (CCSVI) in a large cohort of volunteers. PLoS One 2011;6:e28062

    CrossRefPubMed
24. 24.↵
    1. Jenkinson M,
    2. Bannister P,
    3. Brady M,
    4. et al

    . Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002;17:825–41

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Zivadinov R,
    2. Rudick RA,
    3. De Masi R,
    4. et al

    . Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 2001;57:1239–47

    CrossRef
26. 26.↵
    1. Seewann A,
    2. Vrenken H,
    3. van der Valk P,
    4. et al

    . Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch Neurol 2009;66:601–09

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Langer-Gould A,
    2. Brara S,
    3. Beaber B,
    4. et al

    . Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology 2013;80:548–52

    CrossRef
28. 28.↵
    1. Morris Z,
    2. Whiteley WN,
    3. Longstreth WT Jr.,
    4. et al

    . Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2009;339:b3016

    Abstract/FREE Full Text
29. 29.↵
    1. Weber F,
    2. Knopf H

    . Incidental findings in magnetic resonance imaging of the brains of healthy young men. J Neurol Sci 2006;240:81–84

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Engell T

    . A clinical patho-anatomical study of clinically silent multiple sclerosis. Acta Neurol Scand 1989;79:428–30

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Wasay M,
    2. Rizvi F,
    3. Azeemuddin M,
    4. et al

    . Incidental MRI lesions suggestive of multiple sclerosis in asymptomatic patients in Karachi, Pakistan. J Neurol Neurosurg Psychiatry 2011;82:83–85

    Abstract/FREE Full Text
32. 32.↵
    1. D'Amico D,
    2. La Mantia L,
    3. Rigamonti A,
    4. et al

    . Prevalence of primary headaches in people with multiple sclerosis. Cephalalgia 2004;24:980–84

    Abstract/FREE Full Text
33. 33.↵
    1. Di Perri C,
    2. Dwyer MG,
    3. Wack DS,
    4. et al

    . Signal abnormalities on 1.5 and 3 Tesla brain MRI in multiple sclerosis patients and healthy controls: a morphological and spatial quantitative comparison study. Neuroimage 2009;47:1352–62

    CrossRefPubMed
34. 34.↵
    1. Sicotte NL,
    2. Voskuhl RR,
    3. Bouvier S,
    4. et al

    . Comparison of multiple sclerosis lesions at 1.5 and 3.0 Tesla. Invest Radiol 2003;38:423–27

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Stankiewicz JM,
    2. Glanz BI,
    3. Healy BC,
    4. et al

    . Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis. J Neuroimaging 2011;21:e50–56

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Enzinger C,
    2. Smith S,
    3. Fazekas F,
    4. et al

    . Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention study. J Neurol 2006;253:1064–70

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Gouw AA,
    2. Seewann A,
    3. van der Flier WM,
    4. et al

    . Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011;82:126–35

    Abstract/FREE Full Text
38. 38.↵
    1. Laule C,
    2. Pavlova V,
    3. Leung E,
    4. et al

    . Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration. J Neuropathol Exp Neurol 2013;72:42–52

    CrossRefPubMed
39. 39.↵
    1. Lebrun C,
    2. Bensa C,
    3. Debouverie M,
    4. et al

    . Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry 2008;79:195–98

    Abstract/FREE Full Text
40. 40.↵
    1. Okuda DT,
    2. Mowry EM,
    3. Cree BA,
    4. et al

    . Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 2011;76:686–92

    CrossRef